Joshua T. White, Chief Economist and Director of the Division of Economic and Risk Analysis (DERA) of the U.S. Securities and Exchange Commission (SEC), recently delivered a compelling speech exploring the intricate relationship between regulation, technological advancement, and the allocation of scarce corporate resources, particularly board and management attention. Delivered to the NACD Nashville Chapter, White’s remarks, while representing his personal views, offered significant insights into the SEC’s economic framework for evaluating regulatory policies and the burgeoning implications of artificial intelligence, or "superintelligence" (SI), on corporate strategy and efficiency.

The core of White’s address revolved around the economic concept of "opportunity cost" and its profound impact on how companies deploy their most valuable, and often most limited, resources. He began by referencing a 2026 Governance Outlook survey by the National Association of Corporate Directors (NACD), which identified shifting economic conditions, artificial intelligence, and regulatory requirements as the top three trends expected to significantly influence companies in the coming year. White proposed to dissect the economic implications of the latter two, highlighting their shared capacity to reshape resource allocation, influence costs, and direct the flow of capital and attention.

"For a board, attention may be the scarcest resource of all," White stated, drawing a parallel to Dolly Parton’s iconic song "9 to 5." He emphasized that despite the extended hours many directors work, the fundamental constraint of 24 hours in a day remains. Every hour dedicated to one task is an hour irrevocably lost for another, underscoring the critical importance of understanding these trade-offs. This principle, he explained, forms the bedrock of how the SEC approaches regulatory analysis and the potential disruptions posed by emerging technologies.

The JOBS Act: A Regulatory Experiment in Resource Reallocation

White then delved into a significant regulatory experiment: the Jumpstart Our Business Startups (JOBS) Act of 2012. He used the example of a small biotech startup, a company with promising drug candidates but no immediate revenue, heavily reliant on external capital for critical operations like scientific research, laboratory construction, and clinical trials. For such entities, every dollar diverted to compliance is a dollar that cannot be invested in advancing their core scientific mission.

The JOBS Act introduced an "on-ramp" for emerging growth companies, offering scaled disclosure requirements and exemptions from certain auditor attestation mandates, specifically Section 404(b) of Sarbanes-Oxley. This created what economists refer to as a "natural experiment" to assess the impact of such compliance relief.

The findings, as presented by White, were striking. Post-JOBS Act, biotech IPO activity increased, with companies going public earlier in the FDA approval process and often focusing on treatments for cancer and rare diseases. More importantly, the research indicated that these companies subsequently exhibited increased patent production, conducted more clinical trials, expanded laboratory staffing, achieved critical FDA approval milestones more frequently, and experienced lower failure rates.

Biotech executives themselves corroborated these findings, reporting that the compliance savings were reinvested directly into research and development. "In other words, reducing one use of resources allowed companies to put more resources somewhere else," White explained. "And in this case, somewhere else was science." Crucially, this reallocation did not come at the expense of financial reporting quality, as research found no evidence of a decline. This suggested that regulatory relief could indeed free up resources for productive reinvestment without compromising transparency or investor protection.

SEC Cost-Benefit Analysis: A Framework for Efficiency

This case study segued into how economists at the SEC approach regulatory decision-making. White outlined the fundamental questions guiding the Commission’s economic analysis for any significant rule: What problem are we trying to solve? What is the current landscape? What are the available alternatives? And what are the potential benefits and costs of action?

Beyond these core inquiries, Congress mandates that the SEC consider whether its rules promote efficiency, competition, and capital formation, alongside investor protection. White elaborated on the concept of "productive efficiency," defined as deriving greater value from available resources, which extend beyond financial capital to include human capital, management time, technology, and board attention.

Compliance requirements, while necessary for disclosure and investor protection, invariably consume these resources. They can necessitate new systems, external advisors, increased staffing, and dedicated management and board oversight. The SEC’s economic analysis weighs the value of the information generated by these compliance efforts against the resources and costs incurred. When technology and markets evolve, potentially altering this balance, simplifying or eliminating a requirement can lead to efficiency gains by freeing up resources for alternative, potentially higher-value uses.

The implication of this resource reallocation is profound. A dollar saved on compliance can be invested in product development, market expansion, technological upgrades, or supply chain optimization. An hour of management time freed from compliance processes can be dedicated to running the business more effectively. Similarly, board time liberated from overseeing compliance can be redirected toward strategic planning, capital allocation, succession planning, and risk management. When these redeployed resources generate greater value, the company achieves enhanced productive efficiency.

White reiterated that regulatory costs are not merely financial outlays; they represent the opportunity cost of what those resources could be doing elsewhere. For directors, this often translates to a critical shortage of time and attention, potentially leaving insufficient bandwidth for crucial strategic decisions. Many of the SEC’s current deregulatory considerations aim to achieve precisely this: freeing up resources for more value-creating activities. However, White stressed that deregulation is subject to the same rigorous economic scrutiny as new regulations. The potential loss of investor protection or valuable information, or the disruption of established systems, must also be carefully evaluated. Furthermore, regulatory costs can disproportionately affect smaller firms, impacting competition and market entry.

Engaging Stakeholders: The Value of Public Comment

White underscored the SEC’s reliance on external input, particularly from industry professionals who possess intimate knowledge of operational realities. He encouraged companies and trade groups to participate in the Commission’s rulemaking process by providing detailed comments. Data on actual costs, cost drivers, the ultimate bearers of these costs, and likely behavioral changes are invaluable for informing the SEC’s economic analyses. This collaborative approach, White suggested, leads to more accurate and effective regulatory outcomes.

Superintelligence: A New Frontier in Efficiency and Attention

Turning to the other significant disruptor identified by NACD – superintelligence (SI) – White observed that while 76% of directors anticipate SI influencing their growth strategies, many companies report modest success in achieving operational efficiencies thus far.

SI possesses the potential to dramatically lower information processing costs, enabling rapid analysis of vast datasets and potentially reducing the expense of information production. However, White cautioned against the simplistic assumption that lower processing costs equate to an imperative to produce more information.

He recalled a previous address to fund compliance professionals, where he highlighted the temptation to disclose more simply because technology makes it easier. "But information still has to be collected, verified, reconciled, and ultimately stood behind," White stated. "SI may reduce the cost of processing information. It does not make reliable information free to produce." The opportunity cost remains: time spent collecting and verifying immaterial information is time not spent on core business functions or strategic oversight.

This underscores the enduring importance of materiality as a guiding principle in disclosure. Materiality ensures that focus remains on information genuinely relevant to investors, rather than on information that is merely producible due to technological advancements. The SEC’s disclosure framework, built around materiality, is therefore resilient to the advent of SI, as it continues to align with fundamental economic considerations.

White presented an efficiency argument for maintaining this discipline. If SI allows a company to generate a disclosure in three days instead of three weeks, the optimal course may not be to fill the remaining two and a half days with more disclosure. Instead, the opportunity exists to return that time to the individuals running the company, allowing them to focus on developing new products, enhancing supply chains, engaging with customers, identifying better investments, or interacting with investors – activities that create tangible value. This mirrors the resource reallocation observed in the JOBS Act study: freed-up resources can be redirected to more productive uses.

For corporate boards, White posited two crucial questions regarding SI: Is SI enabling the company to perform necessary work more efficiently? And, critically, what is the company doing with the reclaimed time and resources? The true promise of SI, he concluded, lies not in an unending output of information, but in the enhanced ability to allocate scarce resources, particularly human attention, to the most impactful endeavors.

Conclusion: The Enduring Economics of Scarcity

White concluded by bringing his discussion full circle, returning to the fundamental concept of scarcity. Boards face this challenge daily when setting agendas, companies confront it when deciding on investments, and regulators grapple with it when evaluating the resource-shifting impacts of rules. The critical question, he urged, is not merely whether something has a cost, but what value is being derived from that cost, and what those resources could be achieving in alternative applications. For the biotech companies studied, a portion of that value was directed towards scientific advancement. For every company represented, the answer will be unique. Identifying the optimal allocation of these scarce resources remains a vital task for both corporate boards and regulators striving to craft effective and efficient policies.

By